Orthocell Ltd. entered a research collaboration agreement with DePuy Synthes Products Inc., a part of the Johnson & Johnson family of companies, for its Ortho-ATI stem cell approach for the regeneration of degenerate tendons and ligaments.
A collaborative study is planned to start in the first quarter of 2017.
The treatment has shown itself to be a cost-effective and durable non-surgical solution for difficult to treat tendon injuries in studies done by Orthocell. It is available in Australia and New Zealand for patients who have failed conservative treatment options such as corticosteroid injections and exercise programs and have ongoing symptoms.
The collaboration was facilitated by Johnson & Johnson Innovation.